Cavo, M., Hillengaß, J., & Goldschmidt, H. (2017). Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: A consensus statement by the International Myeloma Working Group. The lancet. Oncology, 18(4), . https://doi.org/10.1016/S1470-2045(17)30189-4
Chicago-Zitierstil (17. Ausg.)Cavo, Michele, Jens Hillengaß, und Hartmut Goldschmidt. "Role of 18F-FDG PET/CT in the Diagnosis and Management of Multiple Myeloma and Other Plasma Cell Disorders: A Consensus Statement by the International Myeloma Working Group." The Lancet. Oncology 18, no. 4 (2017). https://doi.org/10.1016/S1470-2045(17)30189-4.
MLA-Zitierstil (9. Ausg.)Cavo, Michele, et al. "Role of 18F-FDG PET/CT in the Diagnosis and Management of Multiple Myeloma and Other Plasma Cell Disorders: A Consensus Statement by the International Myeloma Working Group." The Lancet. Oncology, vol. 18, no. 4, 2017, https://doi.org/10.1016/S1470-2045(17)30189-4.